Study on the correlation between acute lymphoblastic leukemia and HLA genes in southern China Han population.
- Author:
Su-Qing GAO
1
;
Zhi-Hui DENG
;
Shi-Zheng JIN
;
Su-Ying ZHANG
;
Xuan ZHANG
;
Guo-Guang WU
Author Information
1. Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen 518035, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Alleles;
Asian Continental Ancestry Group;
genetics;
Chi-Square Distribution;
Child;
Child, Preschool;
China;
Female;
Gene Frequency;
Genetic Predisposition to Disease;
ethnology;
HLA-A Antigens;
genetics;
HLA-B Antigens;
genetics;
HLA-DR Antigens;
genetics;
HLA-DRB1 Chains;
Humans;
Male;
Middle Aged;
Precursor Cell Lymphoblastic Leukemia-Lymphoma;
ethnology;
genetics
- From:
Journal of Experimental Hematology
2005;13(2):210-214
- CountryChina
- Language:Chinese
-
Abstract:
To study the correlation between acute lymphoblastic leukemia (ALL) and HLA-A, B and DRB1 gene in southern Chinese Han population and to investigate the susceptible HLA gene to ALL, a total of 4707 healthy volunteer bone marrow donors from southern Chinese Han population were used as a control group, 201 patients diagnosed as patient group from southern Han individuals were genotyped at HLA-A, B and DRB1 loci by PCR-SSP, PCR-SSOP and SBT. HLA allele frequency and its distribution of ALL patient group were compared with the control group by using chi(2) test, and calculated the statistic value of relative risk (RR), pathogenicity score (EF) and preventive score (PF). The results showed that in comparison with the control group, the gene frequence of HLA-A26, B56 and DR9 increased significantly, but the gene frequence of HLA-A30, A33 and B58 allele frequency decreased significantly for patients with ALL. It is concluded that HLA-A26, B56 and DR9 gene have a high correlation with ALL and seem to contribute the genetic susceptibility to ALL in southern Chinese Han populations. However, HLA-A30, A33 and B58 gene seem to have protective role for southern Han individuals suffered from ALL.